LGI1 and autoimmune encephalitis: A 48-year-old man was diagnosed with anti-leucine-rich glioma inactivated 1 (LGI1) autoimmune encephalitis after he developed fast cognitive deterioration and hyponatremia following his second dose of the BNT162b2 mRNA vaccine [209].